Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Sales | 69,640 | 65,474 | 69,320 | 62,213 | 59,148 |
| Cost of Goods | 23,053 | 20,278 | 19,427 | 15,901 | 18,929 |
| Gross Profit | 46,587 | 45,196 | 49,893 | 46,312 | 40,219 |
| Operating Expenses | 53,084 | 47,728 | 51,133 | 42,104 | 39,330 |
| Operating Income | -6,444 | -2,254 | -813 | 5,109 | 1,818 |
| Interest Expense | 1,733 | 1,868 | 1,884 | 1,905 | 1,940 |
| Other Income | 277 | 300 | 91 | 163 | 169 |
| Pre-tax Income | -7,900 | -3,822 | -2,606 | 3,367 | 47 |
| Income Tax | 58 | 32 | -108 | 281 | 39 |
| Net Income Continuous | -7,958 | -3,854 | -2,498 | 3,086 | 8 |
| Net Income | $-7,958 | $-3,854 | $-2,498 | $3,086 | $8 |
| EPS Basic Total Ops | -0.21 | -0.10 | -0.06 | 0.08 | 0.00 |
| EPS Basic Continuous Ops | -0.21 | -0.10 | -0.07 | 0.08 | 0.00 |
| EPS Diluted Total Ops | -0.21 | -0.10 | -0.07 | 0.08 | 0.00 |
| EPS Diluted Continuous Ops | -0.21 | -0.10 | -0.06 | 0.08 | 0.00 |
| EBITDA(a) | $-2,086 | $2,053 | $3,448 | $9,081 | $5,743 |